US economy adds 143,000 jobs in January, unemployment rate falls to 4%

XETRA - Delayed Quote EUR

BioNxt Solutions Inc. (BXT.DE)

0.2710

0.0000

(0.00%)

As of February 6 at 5:35:59 PM GMT+1. Market Open.

Key Events

Loading Chart for BXT.DE

9/21 12:03 PM

DELL

Previous Close 0.2710
Open 0.2620
Bid 0.2600 x --
Ask 0.3050 x --
Day's Range 0.2620 - 0.2960
52 Week Range 0.1200 - 0.4700
Volume 2,467
Avg. Volume 26,788
Market Cap (intraday) 30.84M
Beta (5Y Monthly) 0.61
PE Ratio (TTM) --
EPS (TTM) -0.0500
Earnings Date --
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est --

BioNxt Solutions Inc. engages in R&D and manufacturing of thin-film (sublingual) and skin patch (transdermal) drug delivery for neurological and autoimmune diseases, enhancing patient compliance and bioavailability. It offers diagnostic screening tests, and new active pharmaceutical production and evaluation, including precision transdermal and oral dissolvable drug formulations; oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.

--

Full Time Employees

December 31

Fiscal Year Ends

Sector

Drug Manufacturers - Specialty & Generic

Industry

Trailing total returns as of 2/7/2025, which may include dividends or other distributions. Benchmark is

S&P/TSX Composite index

.

YTD Return

BXT.DE

0.00%

S&P/TSX Composite index

3.63%

1-Year Return

BXT.DE

34.70%

S&P/TSX Composite index

21.75%

3-Year Return

BXT.DE

73.69%

S&P/TSX Composite index

19.95%

5-Year Return

BXT.DE

86.45%

S&P/TSX Composite index

43.69%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

BioNxt Solutions Inc.

0.2710

0.00%

Mkt Cap EUR 30.84M

Industry Drug Manufacturers—Specialty & Generic

CANNOVUM CANNABIS AG I

0.4800

+5.26%

Mkt Cap EUR 1.109M

Industry Drug Manufacturers—Specialty & Generic

2.2600

-1.95%

Mkt Cap EUR 13.734M

Industry Drug Manufacturers—Specialty & Generic

4.5820

-0.43%

Mkt Cap EUR 41.438B

Industry Drug Manufacturers—Specialty & Generic

Cantourage Group SE

4.7000

-2.49%

Mkt Cap EUR 59.57M

Industry Drug Manufacturers—Specialty & Generic

166.96

-1.65%

Mkt Cap EUR 75.327B

Industry Drug Manufacturers—Specialty & Generic

PharmaSGP Holding SE

28.00

+0.72%

Mkt Cap EUR 335.726M

Industry Drug Manufacturers—Specialty & Generic

10.53

-0.14%

Mkt Cap EUR 12.569B

Industry Drug Manufacturers—Specialty & Generic

Apontis Pharma AG

11.15

-6.30%

Mkt Cap EUR 94.775M

Industry Drug Manufacturers—Specialty & Generic

Tilray Brands, Inc.

0.9880

-6.62%

Mkt Cap EUR 922.765M

Industry Drug Manufacturers—Specialty & Generic

Dermapharm Holding SE

39.45

+0.90%

Mkt Cap EUR 2.124B

Industry Drug Manufacturers—Specialty & Generic

Valuation Measures

As of 2/6/2025

Market Cap

32.10M
Enterprise Value

35.82M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

1.05k
Price/Book (mrq)

--
Enterprise Value/Revenue

1.27k
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

-228.25%
Return on Equity (ttm)

--
Revenue (ttm)

30.64k
Net Income Avi to Common (ttm)

-6.42M
Diluted EPS (ttm)

-0.0500

Balance Sheet and Cash Flow

Total Cash (mrq)

309.62k
Total Debt/Equity (mrq)

--
Levered Free Cash Flow (ttm)

-2.75M